News

Under the agreement, a subsidiary of GlaxoSmithKline (GSK) will commence a cash tender offer to purchase all of the outstanding shares of Sirtris, at $22.50 per share followed

Pierre Labbe was most recently vice president and CFO of Plexmar Resources. Prior to Plexmar, Mr Labbe spent three years as vice president, CFO and secretary of Medicago.

ARC1779, a novel aptamer therapeutic agent, is indicated for the treatment of a rare, life-threatening blood disorder known as thrombotic thrombocytopenic purpura, or TTP. ARC1779 is currently in

This transaction is consistent with Simcere’s strategy to focus on first-to-market and innovative new drugs and expand its anticancer product portfolio.

The round was led by Unilever Technology Ventures, Novartis Venture Funds, the ATDC Seed Capital Fund, as well as a number of private investors. Rafael Andino, founder of

Champix’s approval in Japan was based on a 12-week, randomized, double-blind, placebo-controlled study in Japanese smokers who wanted to quit smoking. The primary endpoint, the percentage of subjects

Colistimethate for Injection, USP, 150mg is generic equivalent of JHP Pharmaceuticals’s Coly-Mycin M parenteral. APP has immediately commenced marketing and shipping the product. APP’s colistimethate is AP-rated, bar-coded

The US and EU trials each consist of two study groups; patients who received the graft/Vascular Wrap combination, and patients who received the graft alone. At the onset

The roll-over study will be open to patients who complete one of the two concurrent Phase III Capacity studies of pirfenidone in idiopathic pulmonary fibrosis (IPF). InterMune expects